300 Tote jährlich – und der Nachschub an Antibiotika stockt
Holger Alich describes the latest findings of the Antimicrobial Resistance Benchmark in Tages-Anzeiger.
Looking at the impact of antimicrobial resistance in Switzerland, Holger Alich outlines the important role that pharmaceutical companies have in tackling drug resistance.
Drawing from the results of the 2020 Benchmark, the article highlights that while progress is happening, and some companies are stepping up, others are either maintaining course, or even backing away from the anti-infectives space. The author looks at what this means for the supply on antibiotics in Switzerland.